,COPS5MK2,COPS5

Ai-Ling Luo1,2, Wen-Ying Zheng1, Qiong Zhang1

  • 1Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510095, China.

概括

COP9信号酶子单元5 (COPS5) 通过抑制铁亡,驱动肝细胞癌 (HCC) 中的索拉芬尼抗性. 用sorafenib抑制COPS5为HCC患者提供了潜在的新治疗策略.